Sort   by:  
 Page size 
UnknownRandomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
Not available
S-EPMC5805479 | biostudies-literature
UnknownLong-Term Follow-Up of the Intergroup Exemestane Study.
Not available
S-EPMC6175047 | biostudies-literature
UnknownDissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
Not available
S-EPMC6491661 | biostudies-literature
UnknownImpact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.
Not available
S-EPMC7612503 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
UnknownTen-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
Not available
S-EPMC7526720 | biostudies-literature
UnknownWide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
Not available
S-EPMC4737890 | biostudies-literature
UnknownGenomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment.
Not available
S-EPMC7446335 | biostudies-literature
UnknownRelationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Not available
S-EPMC9466340 | biostudies-literature
UnknownShort-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study.
Not available
S-EPMC12368290 | biostudies-literature
Sort   by:  
 Page size